Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Ajanta Pharma Limited ( (IN:AJANTPHARM) ) has provided an update.
Ajanta Pharma Limited has announced that its Board of Directors will meet on November 3, 2025, to consider the declaration of the first interim dividend for the financial year ending March 31, 2026. The company has set November 10, 2025, as the record date for the dividend payment, pending approval. This decision is part of the company’s ongoing financial management and could impact shareholder returns, reflecting the company’s financial health and commitment to returning value to its investors.
More about Ajanta Pharma Limited
Ajanta Pharma Limited is a pharmaceutical company based in Mumbai, India. The company is involved in the development, manufacturing, and marketing of pharmaceutical products, with a focus on providing healthcare solutions across various therapeutic segments.
Average Trading Volume: 3,187
Technical Sentiment Signal: Sell
Current Market Cap: 306.6B INR
See more data about AJANTPHARM stock on TipRanks’ Stock Analysis page.